IonQ, Closes

IonQ Closes $1.8B Foundry Deal, but Washington's Silence Still Hangs Over the Stock

Published on 08/02/2026 at 13:32 | Redaktion boerse-global.de

IonQ completes $1.8B SkyWater acquisition but was excluded from CHIPS Act funding. Investors weigh vertical integration against government signal.

IonQ Stock: CHIPS Act Snub vs SkyWater Deal — What Matters?
IonQ Closes $1.8B Foundry Deal, but Washington's Silence Still Hangs Over the Stock Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

The quantum computing pure-play has spent the past week trying to shake off a nagging contradiction: it just became a vertically integrated chipmaker with a US-owned fab, yet the government that keeps signing its defense contracts passed it over for direct CHIPS Act funding. Investors are left weighing which signal matters more.

IonQ completed its acquisition of SkyWater Technology on Friday, July 31, 2026, a $1.8 billion transaction that transforms the company from hardware developer into an integrated manufacturer. SkyWater, the largest purely American semiconductor foundry, now operates as a wholly owned subsidiary, continuing to serve its existing defense and industrial clients while prioritizing IonQ's quantum hardware roadmap. Management expects the vertical integration to accelerate work on the fifth-generation "Tempo" systems and future 256-qubit processors, while onshore fabrication reduces supply-chain exposure and improves trapped-ion performance.

The stock closed the week at €31.66, up 2.10% on the day and 9.64% over seven sessions. Those gains, however, only scratch the surface of a deeper slide. The shares remain 56.68% below the 52-week high of €73.10 set in October 2025, and the monthly picture is harsher still: down roughly 30% over the past month and nearly 20% year to date.

The market's ambivalence is understandable given the political wrinkle. In May, Washington allocated $2.013 billion from the CHIPS Act to nine quantum computing firms, with seven — including Rigetti, D-Wave Quantum, and Infleqtion — receiving direct equity stakes. IonQ, the largest publicly traded trapped-ion quantum pure-play, was conspicuously absent. The Commerce Department never publicly explained the omission, and analysts initially read it as a clear negative. The stock lagged behind peers that received government backing even as the broader quantum sector rallied.

Should investors sell immediately? Or is it worth buying IonQ?

The interpretation later softened. B. Riley analysts argued the exclusion carries less weight than feared, pointing to IonQ's $3.3 billion cash reserve, a new HAQ contract with DARPA, and the SkyWater acquisition as evidence that the company's strategy targets defense and intelligence work rather than conventional CHIPS grants. Still, skepticism lingers: prediction markets now price a 21% chance of a retroactive government stake in IonQ by year-end, up from 13% just days ago — a bet on correcting an anomaly, not confirmation of one.

The timing of the snub makes it all the more puzzling. IonQ's first-quarter 2026 results showed record revenue of $64.7 million, up 755% year over year, marking the fourth consecutive quarter of beating its own guidance. The exclusion, in other words, arrived on the back of operational strength, not weakness — a structural gap that no performance-based explanation has yet filled.

The next test comes Wednesday, August 5, when IonQ reports second-quarter earnings after the close. Analysts expect revenue near $66.5 million, implying growth of over 200% from the prior year. Investors will be watching for new commercial contracts and any detail on how the SkyWater integration affects the path to profitability. The company also remains part of major government programs, including the Missile Defense Agency's SHIELD initiative, which carries a contract ceiling of up to $151 billion for eligible providers.

IonQ at a turning point? This analysis reveals what investors need to know now.

For those considering entry, the risk profile is stark. The 30-day annualized volatility sits near 77%, and the RSI of 40.7 shows the stock has exited oversold territory without reclaiming the neutral 50 level. The average analyst price target stands at €59.29, roughly 87% above Friday's close — a spread that suggests either persistent doubts about near-term execution or genuine conviction that the recent sell-off overshot the fundamentals.

IonQ now occupies an unusual position: operationally integrated, politically overlooked, and chart-wise far below its moving averages. Whether Washington eventually closes the gap — through a second funding round, a bilateral arrangement, or simply continued reliance on IonQ's existing defense contracts — may prove as decisive for the next major move as any single earnings report.

Ad

IonQ Stock: New Analysis - 2 August

Fresh IonQ information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated IonQ analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US46222L1089 | IONQ | boerse | 69910310 |